• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Stahl's Illustrated Antidepressants

Stahl's Illustrated Antidepressants

9780521758529
314.94 zł
283.44 zł Save 31.50 zł Tax included
Lowest price within 30 days before promotion: 283.44 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
All of the titles in the Stahls Illustrated Series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahls Essential Psychopharmacology, 3rd Edition and The Prescribers Guide. The texts in this user-friendly series can be supplements to figures, images, and tables. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahls Illustrated Series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualize complex pharmacologies. And, to help guide the reader toward more in-depth learning about particular concepts, each book ends with a Suggested Reading section.
Product Details
97710
9780521758529
9780521758529

Data sheet

Publication date
2009
Issue number
1
Cover
paperback
Pages count
200
Dimensions (mm)
148.00 x 207.00
Weight (g)
290
  • 1. Neurobiology of depression; 2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); 3. Norepinephrine and dopamine reuptake inhibitors (NDRIs) and selective norepinephrine reuptake inhibitors (NRIs); 4. Alpha 2 antagonists as serotonin and norepinephrine; 5. Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs); 6. Building a treatment plan with novel treatment and augmentation options for depression; 7. Depression in women:: treating symptoms throughout the life span; 8. Pharmacokinetics and algorithms to treat depression.
Comments (0)